Synlett 2013; 24(19): 2563-2566
DOI: 10.1055/s-0033-1340161
letter
© Georg Thieme Verlag Stuttgart · New York

A Mild and Convenient Base-Catalysed Approach to Disubstituted Epidithiodiketopiperazines

Bruno C. Sil
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK   Fax: +44(20)7535964   Email: [email protected]
,
Stephen T. Hilton*
UCL School of Pharmacy, 29-39 Brunswick Square, London, WC1N 1AX, UK   Fax: +44(20)7535964   Email: [email protected]
› Author Affiliations
Further Information

Publication History

Received: 22 August 2013

Accepted after revision: 29 September 2013

Publication Date:
05 November 2013 (online)


Abstract

A novel base-catalysed approach to disubstituted epidithiodiketopiperazines (ETP) is described. The synthetic route involves a multicomponent reaction of a diacetoxyacetamide with a range of different amines and p-methoxybenzylmercaptan to generate the protected ETP core.

 
  • References and Notes

  • 1 Aliev AE, Hilton ST, Motherwell WB, Selwood DL. Tetrahedron Lett. 2006; 47: 2387
  • 2 Cook KM, Hilton ST, Mecinovic J, Motherwell WB, Figg WD, Schofield CJ. J. Biol. Chem. 2009; 284: 26831
    • 3a Hilton ST, Motherwell WB, Potier P, Pradet C, Selwood DL. Bioorg. Med. Chem. Lett. 2005; 15: 2239
    • 3b Block KM, Wang H, Szabo LZ, Polaske NW, Henchey LK, Dubey R, Kushal S, Laszlo CF, Makhoul J, Song Z, Meuillet EJ, Olenyuk BZ. J. Am. Chem. Soc. 2009; 131: 18078
    • 3c Waring P, Beaver J. Gen. Pharmacol. 1996; 27: 1311
    • 3d Chai CL, Waring P. Redox Reports 2000; 5: 257
    • 3e Waring P, Eichner RD, Müllbacher A. Med. Res. Rev. 1988; 8: 499
    • 3f Johnson JR, Bruce WF, Dutcher JD. J. Am. Chem. Soc. 1943; 65: 2005
    • 3g Gardiner DM, Waring P, Howlett BJ. Microbiology 2005; 151: 1021
    • 4a Isham CR, Tibodeau JD, Bossou AR, Merchan JR, Bible KC. Br. J. Cancer 2012; 106: 314
    • 4b Staab A, Loeffler J, Said HM, Diehlmann D, Katzer A, Beyer M, Fleischer M, Schwab F, Baier K, Einsele H, Flentje M, Vordermark D. BMC Cancer 2007; 7: 213
    • 4c Yano K, Horinaka M, Yoshida T, Yasuda T, Taniguchi H, Goda AE, Wakada M, Yoshikawa S, Nakamura T, Kawauchi A, Miki T, Sakai T. Int. J. Oncol. 2011; 38: 365
  • 5 Hilton ST, Motherwell WB, Selwood DL. Synlett 2004; 2609
    • 6a Öhler E, Tataruch F, Schmidt U. Chem. Ber. 1972; 105: 3658
    • 6b Öhler E, Poisel H, Tataruch F, Schmidt U. Chem. Ber. 1972; 105: 635
    • 6c Kishi Y, Fukuyama T, Nakatsuka S. J. Am. Chem. Soc. 1973; 95: 6490
    • 6d Baumann E, Fromm E. Ber. 1891; 24: 1441
    • 6e Kim J, Ashenhurst JA, Movassaghi M. Science 2009; 324: 238
    • 6f Kim J, Movassaghi M. J. Am. Chem. Soc. 2010; 132: 14376
    • 6g Iwasa E, Hamashima Y, Fujishiro S, Hashizume D, Sodeoka M. Tetrahedron 2011; 67: 6587
    • 7a Nicolaou KC, Giguere D, Totokotsopoulos S, Sun Y.-P. Angew. Chem. Int. Ed. 2012; 51: 728
    • 7b Codelli JA, Puchlopek AL. A, Reisman SE. J. Am. Chem. Soc. 2012; 134: 1930
  • 8 General Procedures Method A: n-Butylamine (0.18 mL, 1.82 mmol) was added to a solution of diacetate 7 (0.31 g, 0.61 mmol) in MeCN (30.0 mL) followed by addition of p-methoxybenzyl-mercaptan (0.13 mL, 0.91 mmol) and the resulting mixture was stirred for 2 min. DMAP (0.04 g, 0.30 mmol) was added in a single portion and the resulting mixture was heated at reflux for 16 h, cooled to r.t. and the solvent was removed under reduced pressure. Purification via Biotage™ Horizon [petroleum spirit (40–60 °C)–EtOAc, 3:1; snap 25 g] gave protected ETP 8 (0.28 g, 80%) as a colourless solid (see ref. 1). Method B: 3-Chlorobenzylamine (0.13 mL, 1.07 mmol) was added to a solution of diacetate 7 (0.18 g, 0.36 mmol) in MeCN (5.00 mL) followed by addition of p-methoxybenzyl-mercaptan (0.07 mL, 0.53 mmol) and the resulting mixture was stirred for 2 min. DMAP (0.02 g, 0.18 mmol) was added and the mixture was heated in the microwave at 150 °C for 5 min, allowed to cool to r.t. and the solvent was removed under reduced pressure. Purification via Biotage™ Horizon [petroleum spirit (40–60 °C)–EtOAc, 3:1; snap 25 g] gave 1-benzyl-4-(3-chlorobenzyl)-3,6-bis[(4-methoxybenzyl)thio]-piperazine-2,5-dione (0.15 g, 68%) as a colourless solid (see ref. 1). Method C: Ethyl 4-aminobutanoate hydrochloride (0.10 g, 0.61 mmol) was added to a solution of diacetate 7 (0.24 g, 0.47 mmol) in MeCN (3 mL) followed by addition of Et3N (0.34 mL, 2.45 mmol) and p-methoxybenzylmercaptan (0.10 mL, 0.73 mmol) and the resulting mixture was stirred for 2 min. DMAP (0.04 g, 0.31 mmol) was added and the mixture was heated in the microwave at 130 °C for 30 min, allowed to cool to r.t. and the solvent was removed under reduced pressure. Purification via Biotage™ Horizon [petroleum spirit (40–60 °C)–EtOAc, 3:1; snap 25 g] gave ethyl 4-{4-benzyl-2,5-bis[(4-methoxybenzyl)thio]-3,6-dioxopiperazin-1-yl}butanoate (0.11 g, 28%) as a colourless solid; mp 105–107 °C. IR: 2931, 1730, 1674 cm–1. 1H NMR (400 MHz, CDCl3): δ = 1.13 (t, J = 7.1 Hz, 3 H, OCH2CH 3), 1.31–1.51 (m, 2 H, CH 2CO2CH2CH3), 1.93–2.02 (m, 2 H, NCH 2CH2), 2.54–2.66 (m, 1 H, NCH 2CH2), 3.41–3.54 (m, 2 H, NCH2Ph), 3.70 (d, J = 12.2 Hz, 1 H, SCH2), 3.73 (s, 3 H, OMe), 3.76 (s, 3 H, OMe), 3.78–3.83 (m, 1 H, SCH2), 3.85 (d, J = 13.9 Hz, 1 H, SCH2), 3.90–4.01 (m, 3 H, CO2CH 2CH3, SCH2), 4.39 (s, 1 H, CHS), 4.21 (s, 1 H, CHS), 5.08 (d, J = 14.5 Hz, 1 H, NCH2), 6.61–6.65 (m, 2 H, ArH), 6.77–6.81 (m, 2 H, ArH), 6.80–6.84 (m, 2 H, ArH), 7.03–7.09 (m, 2 H, ArH), 7.11–7.13 (m, 1 H, ArH), 7.23–7.27 (m, 2 H, ArH), 7.30–7.34 (m, 2 H, ArH). 13C NMR (100 MHz, CDCl3): δ = 14.04 (CO2Et), 21.95 (CH2), 31.29 (CH2), 36.10 (SCH2), 36.80 (SCH2), 43.13 (CH2), 46.00 (CH2), 55.14 (OMe), 55.15 (OMe), 57.23 (CHS), 59.26 (CHS), 60.24 (CO2Et), 113.96 (ArH), 114.01 (ArH), 127.72 (ArH), 128.46 (ArH), 128.52 (ArH), 128.56 (C), 128.73 (C), 130.60 (ArH), 130.67 (ArH), 134.84 (C), 159.01 (C), 159.03 (C), 164.92 (C), 165.07 (C), 172.26 (C). MS: m/z = 645 (100%) [M + Na]+. HRMS: m/z [M + Na]+ calcd for C33H38N2O6S2Na: 645.2069; found: 645.2069.